View in EDS HTML Full Text PDF Full Text

Impact of a Harm-Reduction Policy on HIV and Hepatitis C Virus Transmission Among Drug Users: Recent French Data—The ANRS-Coquelicot Study.

Saved in:
Bibliographic Details
Title: Impact of a Harm-Reduction Policy on HIV and Hepatitis C Virus Transmission Among Drug Users: Recent French Data—The ANRS-Coquelicot Study.
Authors: Jauffret-Roustide, M. (AUTHOR), Emmanuelli, J. (AUTHOR), Quaglia, M. (AUTHOR), Barin, F. (AUTHOR), Arduin, P. (AUTHOR), Laporte, A. (AUTHOR), Desenclos, J.-C. (AUTHOR)
Source: Substance Use & Misuse. 2006, Vol. 41 Issue 10-12, p1603-1621. 19p. 2 Charts, 1 Graph.
Subjects: AIDS prevention, Harm reduction, Risk management in business, HIV, Hepatitis viruses, HIV infections, Liver diseases, Hepatitis C virus, Viral hepatitis, Flaviviruses, Lentivirus diseases
Abstract: In France a harm-reduction policy was implemented in the late 1980s with the aim of reducing the prevalence of HIV and hepatitis C virus (HCV) infection among drug users. The ANRS-Coquelicot survey was designed to measure the prevalence of HIV and HCV infection among drug users and to examine determinants of at-risk behaviors. In 2002, information was collected from 166 drug users recruited in all types of services specializing in drug use intervention and harm reduction in Marseille, France. Self-reported HIV and HCV serostatus was compared with the results of serological tests done on capillary blood collected on filter paper. The self-reported and biologically documented prevalence rates of HIV infection were identical (22%). In contrast, the self-reported prevalence of HCV infection was 52%, whereas the biologically documented prevalence was 73%. Overall, 30% of HCV-infected drug users were unaware of their status. Forty-four percent of drug users under 30 years of age were HCV seropositive, suggesting that they had been infected early during drug use. The harm-reduction policy seems to have had a marked impact on HIV transmission among drug users but a much more limited impact on HCV transmission. The limitations and implications of the study are discussed. [ABSTRACT FROM AUTHOR]
Copyright of Substance Use & Misuse is the property of Taylor & Francis Ltd and its content may not be copied or emailed to multiple sites without the copyright holder's express written permission. Additionally, content may not be used with any artificial intelligence tools or machine learning technologies. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
Database: Psychology and Behavioral Sciences Collection
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: pbh
DbLabel: Psychology and Behavioral Sciences Collection
An: 22493966
AccessLevel: 6
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Impact of a Harm-Reduction Policy on HIV and Hepatitis C Virus Transmission Among Drug Users: Recent French Data—The ANRS-Coquelicot Study.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AR" term="%22Jauffret-Roustide%2C+M%2E%22">Jauffret-Roustide, M.</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Emmanuelli%2C+J%2E%22">Emmanuelli, J.</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Quaglia%2C+M%2E%22">Quaglia, M.</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Barin%2C+F%2E%22">Barin, F.</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Arduin%2C+P%2E%22">Arduin, P.</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Laporte%2C+A%2E%22">Laporte, A.</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Desenclos%2C+J%2E-C%2E%22">Desenclos, J.-C.</searchLink> (AUTHOR)
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22Substance+Use+%26+Misuse%22">Substance Use & Misuse</searchLink>. 2006, Vol. 41 Issue 10-12, p1603-1621. 19p. 2 Charts, 1 Graph.
– Name: Subject
  Label: Subjects
  Group: Su
  Data: <searchLink fieldCode="DE" term="%22AIDS+prevention%22">AIDS prevention</searchLink><br /><searchLink fieldCode="DE" term="%22Harm+reduction%22">Harm reduction</searchLink><br /><searchLink fieldCode="DE" term="%22Risk+management+in+business%22">Risk management in business</searchLink><br /><searchLink fieldCode="DE" term="%22HIV%22">HIV</searchLink><br /><searchLink fieldCode="DE" term="%22Hepatitis+viruses%22">Hepatitis viruses</searchLink><br /><searchLink fieldCode="DE" term="%22HIV+infections%22">HIV infections</searchLink><br /><searchLink fieldCode="DE" term="%22Liver+diseases%22">Liver diseases</searchLink><br /><searchLink fieldCode="DE" term="%22Hepatitis+C+virus%22">Hepatitis C virus</searchLink><br /><searchLink fieldCode="DE" term="%22Viral+hepatitis%22">Viral hepatitis</searchLink><br /><searchLink fieldCode="DE" term="%22Flaviviruses%22">Flaviviruses</searchLink><br /><searchLink fieldCode="DE" term="%22Lentivirus+diseases%22">Lentivirus diseases</searchLink>
– Name: Abstract
  Label: Abstract
  Group: Ab
  Data: In France a harm-reduction policy was implemented in the late 1980s with the aim of reducing the prevalence of HIV and hepatitis C virus (HCV) infection among drug users. The ANRS-Coquelicot survey was designed to measure the prevalence of HIV and HCV infection among drug users and to examine determinants of at-risk behaviors. In 2002, information was collected from 166 drug users recruited in all types of services specializing in drug use intervention and harm reduction in Marseille, France. Self-reported HIV and HCV serostatus was compared with the results of serological tests done on capillary blood collected on filter paper. The self-reported and biologically documented prevalence rates of HIV infection were identical (22%). In contrast, the self-reported prevalence of HCV infection was 52%, whereas the biologically documented prevalence was 73%. Overall, 30% of HCV-infected drug users were unaware of their status. Forty-four percent of drug users under 30 years of age were HCV seropositive, suggesting that they had been infected early during drug use. The harm-reduction policy seems to have had a marked impact on HIV transmission among drug users but a much more limited impact on HCV transmission. The limitations and implications of the study are discussed. [ABSTRACT FROM AUTHOR]
– Name: AbstractSuppliedCopyright
  Label:
  Group: Ab
  Data: <i>Copyright of Substance Use & Misuse is the property of Taylor & Francis Ltd and its content may not be copied or emailed to multiple sites without the copyright holder's express written permission. Additionally, content may not be used with any artificial intelligence tools or machine learning technologies. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract.</i> (Copyright applies to all Abstracts.)
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=pbh&AN=22493966
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1080/10826080600847951
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        PageCount: 19
        StartPage: 1603
    Subjects:
      – SubjectFull: AIDS prevention
        Type: general
      – SubjectFull: Harm reduction
        Type: general
      – SubjectFull: Risk management in business
        Type: general
      – SubjectFull: HIV
        Type: general
      – SubjectFull: Hepatitis viruses
        Type: general
      – SubjectFull: HIV infections
        Type: general
      – SubjectFull: Liver diseases
        Type: general
      – SubjectFull: Hepatitis C virus
        Type: general
      – SubjectFull: Viral hepatitis
        Type: general
      – SubjectFull: Flaviviruses
        Type: general
      – SubjectFull: Lentivirus diseases
        Type: general
    Titles:
      – TitleFull: Impact of a Harm-Reduction Policy on HIV and Hepatitis C Virus Transmission Among Drug Users: Recent French Data—The ANRS-Coquelicot Study.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Jauffret-Roustide, M.
      – PersonEntity:
          Name:
            NameFull: Emmanuelli, J.
      – PersonEntity:
          Name:
            NameFull: Quaglia, M.
      – PersonEntity:
          Name:
            NameFull: Barin, F.
      – PersonEntity:
          Name:
            NameFull: Arduin, P.
      – PersonEntity:
          Name:
            NameFull: Laporte, A.
      – PersonEntity:
          Name:
            NameFull: Desenclos, J.-C.
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 09
              Text: 2006
              Type: published
              Y: 2006
          Identifiers:
            – Type: issn-print
              Value: 10826084
          Numbering:
            – Type: volume
              Value: 41
            – Type: issue
              Value: 10-12
          Titles:
            – TitleFull: Substance Use & Misuse
              Type: main
ResultId 1